Dr
Klinikum rechts der Isar, department of nuclear medicine, Technical University of Munich, Munich, Germany
Author in the following contributions
- The response of human papillomavirus associated head and neck squamous cell carcinoma cell lines on standard therapy and treatment with an experimental alpha-particle emitter immunoconjugate targeting EGFR (Bi-213-Cetuximab)
- Safety and efficacy of Ac-225-PSMA-617 in mCRPC after failure of Lu-177-PSMA